Hardeep Minhas
Foot & Ankle Surgery · Michigan City, INNPI 1033557830
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (31.2%), other and education — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Acera Surgical, Inc. at 31.9% of the total. 2025 is the largest year on record at $5,876, 3.9 times the $1,521 reported in 2019.
Across 216 payments — averaging $70.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acera Surgical, Inc.$5K
- Pathway Medical Partners, LLC$4K
- Stryker$1K
- Treace Medical Concepts, Inc.$1K
- Smith+Nephew$778
- Kerecis Limited$611
- plus $2K from 29 others
What the payments were for
- Speaking & faculty fees$871%
- Travel & lodging$1,45010%
- Food & beverage$4,72231%
- Education$4,00026%
- Gifts$1731%
- Other$4,69031%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acera Surgical, Inc. | 2 | $4,824 |
| Pathway Medical Partners, LLC | 1 | $4,000 |
| Stryker(2 entities) | 46 | $1,363 |
| Treace Medical Concepts, Inc. | 13 | $1,298 |
| Smith+Nephew | 58 | $778 |
| Kerecis Limited | 7 | $611 |
| Paragon 28, Inc. | 5 | $547 |
| Organogenesis Inc. | 19 | $411 |
| Paratek Pharmaceuticals, Inc. | 21 | $215 |
| Johnson & Johnson | 3 | $125 |
| Amgen | 1 | $125 |
| Argentum Medical | 1 | $79 |
| Orthofix Medical, Inc. | 7 | $74 |
| Fusion Orthopedics USA, LLC | 1 | $73 |
| Medshape, Inc. | 2 | $64 |
| Encore Medical, LP | 1 | $63 |
| Hartmann USA, Inc. | 3 | $52 |
| KCI USA, Inc. | 2 | $47 |
| Mimedx Group, Inc. | 2 | $40 |
| Integra Lifesciences Corporation | 2 | $36 |
| Trilliant Surgical LLC. | 2 | $33 |
| Osiris Therapeutics Inc. | 2 | $33 |
| Arthrosurface Incorporated | 2 | $28 |
| Convatec Inc. | 1 | $26 |
| Abbott | 1 | $22 |
| Linvatec Corporation | 1 | $21 |
| Lifenet Health | 1 | $20 |
| Alafair Biosciences, Inc. | 1 | $20 |
| Electronic Waveform Lab, Inc. | 2 | $16 |
| Solventum Corporation | 1 | $15 |
| Merck | 1 | $14 |
| Polarityte, Inc. | 1 | $13 |
| Avanos Medical | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Bioventus LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Restrata Wound Matrix$4,824
- Lapiplasty System$1,019
- Portfolio$488
- Kerecis Omega3 Wound$383
- Kerecis Omega3 Surgibind$383
- Kerecis Omega3 GraftGuide$383
- Kerecis Omega3 SurgiClose$383
- INFINITY$173
- CARTIVA$138
- KRYSTEXXA$125
How this compares
$15,123 in reported general payments places this provider in the 80th percentile of 212 foot & ankle surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 20 | $9,042 |
| Diclofenac Sodium ErDiclofenac Sodium | 35 | $747 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 31 | $703 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 57 | $498 |
| Ciclopirox | 22 | $484 |
| Terbinafine Hcl | 37 | $430 |
| Triamcinolone Acetonide | 16 | $362 |
| Methylprednisolone | 29 | $146 |
| Clindamycin Hcl | 14 | $130 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $102 |
| Prednisone | 17 | $26 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $778 | $9,04220 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 212 foot & ankle surgery providers in Indiana.
Other foot & ankle surgery in Michigan City
- Aamir MahmoodMichigan City$37K
- Joseph WilsonMichigan City$17K
- Steven HerbstMuncie$1.6M
- Douglas BlacklidgeKokomo$689K
- Patrick DeheerIndianapolis$493K
- Scott NevilleMooresville$353K
- Travis MontgomeryWestfield$345K
- Robert Clemency IiiSchererville$215K
- William AdamsGreenfield$178K
- Steven DouthettFort Wayne$153K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.